Trademark Data
(111) Registration Number
018887467
(151) Date of the registration
10-07-2023
(210) Serial number of the application
018887467
(220) Date of filing of the application
13-06-2023
(180) Expected expiration date of the registration/renewal
13-06-2033
(731) Name and address of the applicant
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. 55 Cambridge Parkway, Suite 800E Cambridge MA 02142 ESTADOS UNIDOS (DE AMÉRICA)
(511) The International Classification of Goods and Services for the Purposes of the Registration of Marks (Nice Classification) and the list of goods and services classified according thereto
5: Encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of rare genetic disorders, cardiovascular diseases, respiratory diseases and infectious diseases; encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of retinal diseases, metabolic disorders, hormonal deficiencies, endocrine diseases and eye diseases and disorders; encapsulated nucleic acids for use as biological therapeutics in gene therapy for the treatment of intestinal diseases, autoimmune/autoinflammatory diseases, inflammatory disorders, musculoskeletal diseases, neurological disorders, hematologic conditions, cutaneous conditions, neurodegenerative diseases, congenital disorders, kidney and urinary diseases, reproductive diseases, mitochondrial diseases, lung disorders, immune system diseases, mouth diseases, digestive diseases.
(541) Reproduction of the mark where the mark is represented in standard characters
RING THERAPEUTICS
(740) Name and address of the representative
HGF BV
(750) Address for correspondence
HGF BV Gedempt Hamerkanaal 147 1021 KP Amsterdam PAÍSES BAJOS
Powered by profitmark.es